Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AblatePal Radiofrequency Ablation System

K-Number: K223135 · 2023-06-30

Decision Date2023-06-30
Product CodeGEI
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

AblatePal Radiofrequency Ablation System is the device name listed in this FDA 510(k) record. The listed applicant is Compal Electronics, Inc.. It received FDA 510(k) clearance on 2023-06-30 under 510(k) number K223135. The device is classified under product code GEI. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AblatePal Radiofrequency Ablation System?

AblatePal Radiofrequency Ablation System is a medical device that received FDA 510(k) clearance on 2023-06-30. The listed applicant is Compal Electronics, Inc.. The 510(k) number is K223135.

When did AblatePal Radiofrequency Ablation System receive FDA 510(k) clearance?

AblatePal Radiofrequency Ablation System received FDA 510(k) clearance on 2023-06-30, under 510(k) number K223135.

Who is the listed applicant for AblatePal Radiofrequency Ablation System?

The FDA 510(k) record lists Compal Electronics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for AblatePal Radiofrequency Ablation System?

The FDA product code for AblatePal Radiofrequency Ablation System is GEI.

Other records listing Compal Electronics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: GEI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.